EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Immune Cells and Immunotherapy in Multiple Myeloma

Vijay Radhakrishnan iD, Upendarrao Golla iD, Avinash Kundadka Kudva iD

Life · 01.04.2024 · 14 (4) · 461

DOI: 10.3390/life14040461 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 01.04.2024. Verfasst von Vijay Radhakrishnan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Ellis Fischel Cancer Center, Roy Blunt NextGen Precision Health Institute, University of Missouri, Columbia, MO 65212, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical signs of multiple myeloma, a plasma cell (PC) dyscrasia, include bone loss, renal damage, and paraproteinemia. It can be defined as the uncontrolled growth of malignant PCs within the bone marrow. The distinctive bone marrow milieu that regulates the progression of myeloma disease involves interactions between plasma and stromal cells, and myeloid and lymphoid cells. These cells affect the immune system independently or because of a complicated web of interconnections, which promotes disease development and immune evasion. Due to the importance of these factors in the onset of disease, various therapeutic strategies have been created that either target or improve the immunological processes that influence disease progression. The immune system has a role in the mechanism of action of multiple myeloma treatments. The main contributions of immune cells to the bone marrow microenvironment, as well as how they interact and how immune regulation might lead to therapeutic effects, are covered in this study.

Schlagwörter

Stichwörter der Autor:innen

CAR T-cellbone marrow microenvironmentimmune cellsimmune checkpoint inhibitorsimmune escapeimmunotherapymultiple myelomaproteasome

Autor:innen und Institutionen

  • Department of Surgery, Ellis Fischel Cancer Center, Roy Blunt NextGen Precision Health Institute, University of Missouri, Columbia, MO 65212, USA.
  • Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
  • Department of Biochemistry, Mangalore University, Mangalagangothri, Mangaluru 574199, India.
  • Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

ORCID-Profile: Vijay Radhakrishnan, Upendarrao Golla, Avinash Kundadka Kudva

Zitieren

APA

Radhakrishnan, V., Golla, U., & Kudva, A. K. (2024). Role of Immune Cells and Immunotherapy in Multiple Myeloma. Life, 14(4), 461. https://doi.org/10.3390/life14040461

Vancouver

Radhakrishnan V, Golla U, Kudva AK. Role of Immune Cells and Immunotherapy in Multiple Myeloma. Life. 2024;14(4):461. doi:10.3390/life14040461

BibTeX
@article{Radhakrishnan2024,
  author = {Radhakrishnan, Vijay and Golla, Upendarrao and Kudva, Avinash Kundadka},
  title = {Role of Immune Cells and Immunotherapy in Multiple Myeloma},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {461},
  doi = {10.3390/life14040461}
}
Kostenlos starten →